AbTherx, Inc.: AbTherx Announces License Agreement with Gilead
License from Gilead grants AbTherx worldwide rights to a novel human therapeutic antibody discovery platformMOUNTAIN VIEW and SAN DIEGO, CA / ACCESSWIRE / June 7, 2023 / AbTherx, Inc., a privately held